• Cefuroxime Axetil Tablets Ip 500 Mg thumbnail 1
  • Cefuroxime Axetil Tablets Ip 500 Mg thumbnail 2
  • Cefuroxime Axetil Tablets Ip 500 Mg thumbnail 3
  • Cefuroxime Axetil Tablets Ip 500 Mg thumbnail 4
Cefuroxime Axetil Tablets Ip 500 Mg

Cefuroxime Axetil Tablets Ip 500 Mg

₹ 5,760/Box

Strength500mg
Packaging Size10*10 Tablets
Packaging TypeBox
BrandCEFUROPECT -500
Manufactured ByMEDIPETUS PHARMA
Shelf Life24 Months
UsageTo treat bacterial infections
AvailabilityIn Stock
Cefuroxime is used to treat bacterial infections in many different parts of the body. It belongs to the class of medicines known as cephalosporin antibiotics. It works by killing bacteria or preventing their growth. However, this medicine will not work for colds, flu, or other virus infections.

Find products similar to Cefuroxime Axetil Tablets Ip 500 Mg

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromPanchkula
ShippingAs per delivery location

Product Image

Cefuroxime Axetil Tablets Ip 500 Mg image 1Cefuroxime Axetil Tablets Ip 500 Mg image 2Cefuroxime Axetil Tablets Ip 500 Mg image 3Cefuroxime Axetil Tablets Ip 500 Mg image 4

About the Company

GST Registration Year
2025
Legal Status of Firm
Limited Company
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
11 To 25 People
Annual Turnover
40 L - 1.5 Cr
IndiaMART Member Since
May 2025
GST
06**********1ZJ

Established in the year of 2025, We “Medipectus Pharma Pvt. Ltd.” are a Manufacturer of Pharmaceutical Tablet & Pharmaceutical Capsules, Pharmaceutical syrup, Pharmaceutical ointments,Pharmaceutical injections etc. We direct all our activities to cater the expectations of customers by providing them with excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, we are grateful to our Mr. Amit , whose continual backing and direction have been useful to us for attaining exponential development in the current market.